Table 3.
Detection rate MRI/US fusion targeted biopsy by size of ROI (n = 148).
| Lesion size | Freq. | Any PCa | Sign PCa |
|---|---|---|---|
| MRI/US Fusion targeted biopsy | |||
| <5 mm | 22 | 11 (50%) | 7 (32%) |
| 5–9 mm | 93 | 39 (42%) | 26 (28%) |
| ≥10 mm | 45 | 28 (62%) | 25 (56%) |
Freq. = frequency, PCa = prostate cancer, Sign = significant, and ROI = region of interest.